Orgenesis Inc. Files 8-K for Material Agreement
Ticker: ORGS · Form: 8-K · Filed: Jan 28, 2025 · CIK: 1460602
| Field | Detail |
|---|---|
| Company | Orgenesis INC. (ORGS) |
| Form Type | 8-K |
| Filed Date | Jan 28, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $5,000,000, $750,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, filing, financials
TL;DR
Orgenesis Inc. filed an 8-K on Jan 28, 2025, reporting a material definitive agreement.
AI Summary
On January 28, 2025, Orgenesis Inc. filed an 8-K report to disclose a material definitive agreement and financial statements. The company, incorporated in Nevada with its principal executive offices in Germantown, MD, is involved in the pharmaceutical preparations industry.
Why It Matters
This filing indicates a significant business event or transaction for Orgenesis Inc., potentially impacting its financial standing and future operations.
Risk Assessment
Risk Level: low — The filing is a standard disclosure of a material agreement and financial statements, not indicating immediate financial distress or significant operational changes.
Key Players & Entities
- Orgenesis Inc. (company) — Registrant
- January 28, 2025 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- Germantown, MD (location) — Principal executive offices
- 20271 Goldenrod Lane (address) — Principal executive offices street
- 20876 (zip_code) — Principal executive offices zip code
- (480) 659-6404 (phone_number) — Registrant's telephone number
FAQ
What type of material definitive agreement did Orgenesis Inc. enter into?
The filing states that an "Entry into a Material Definitive Agreement" is an item of disclosure, but the specific details of the agreement are not provided in this excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on January 28, 2025.
Where are Orgenesis Inc.'s principal executive offices located?
Orgenesis Inc.'s principal executive offices are located at 20271 Goldenrod Lane, Germantown, MD 20876.
What is Orgenesis Inc.'s SIC code?
Orgenesis Inc.'s Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
What is the Commission File Number for Orgenesis Inc.'s 8-K filing?
The Commission File Number for Orgenesis Inc.'s 8-K filing is 001-38416.
Filing Stats: 1,021 words · 4 min read · ~3 pages · Grade level 13.1 · Accepted 2025-01-28 08:00:21
Key Financial Figures
- $5,000,000 — d to invest up to Five Million Dollars ($5,000,000) over a 24-month period (unless otherwi
- $750,000 — securities. The Investor agrees to fund $750,000 upon the Registration Statement being d
Filing Documents
- form8-k.htm (8-K) — 41KB
- ex10-1.htm (EX-10.1) — 237KB
- ex10-2.htm (EX-10.2) — 112KB
- ex99-1.htm (EX-99.1) — 9KB
- ex99-1.jpg (GRAPHIC) — 22KB
- 0001493152-25-003914.txt ( ) — 672KB
- orgs-20250128.xsd (EX-101.SCH) — 3KB
- orgs-20250128_lab.xml (EX-101.LAB) — 33KB
- orgs-20250128_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ORGENESIS INC. Date: January 28, 2025 By: /s/ Victor Miller Victor Miller Chief Financial Officer, Treasurer and Secretary